newsfilter
← Latest News
GlobeNewswire·

Sandoz receives FDA approval for first and only denosumab biosimilars

MEDIA RELEASE Wyost® (denosumab-bddz) and Jubbonti® (denosumab-bddz) interchangeable with and approved by FDA for all indications of reference medicines Xgeva ®* (denosumab) and Prolia®*